Table 3.
Duration of sick leave in days, by SARS-CoV-2 serology test result and age.
| Antibody status | Age | Cumulative number of sick leave days over the perioda | ||||
|---|---|---|---|---|---|---|
| 0 days n (%) | 1–5 days n (%) | 6–10 days n (%) | 11–15 days n (%) | ≥ 16 days n (%) | ||
| Negative | < 29 | 857 (67.3) | 312 (24.5) | 78 (6.1) | 13 (1.0) | 13 (1.0) |
| 30–39 | 1815 (65.1) | 677 (24.3) | 209 (7.5) | 57 (2.0) | 31 (1.1) | |
| 40–49 | 1934 (67.4) | 617 (21.5) | 212 (7.4) | 54 (1.9) | 51 (1.8) | |
| 50–59 | 1897 (68.9) | 519 (18.9) | 211 (7.7) | 77 (2.8) | 49 (1.8) | |
| 60+ | 1282 (72.7) | 287 (16.3) | 119 (6.8) | 46 (2.6) | 30 (1.7) | |
| Total n, % (95% CI) | 7875, 68.8 (67.9–69.6) | 2412, 21.1 (20.3–21.8) | 829, 7.2 (6.8–7.7) | 247, 2.2 (1.9–2.4) | 174, 1.5 (1.3–1.7) | |
| Positive | < 29 | 109 (43.8) | 63 (25.3) | 55 (22.1) | 16 (6.4) | 6 (2.4) |
| 30–39 | 143 (37.3) | 117 (30.6) | 79 (21.4) | 36 (9.4) | 8 (2.1) | |
| 40–49 | 143 (38.7) | 97 (26.2) | 79 (21.4) | 42 (11.4) | 9 (2.4) | |
| 50–59 | 113 (36.1) | 60 (19.2) | 89 (28.4) | 29 (9.3) | 22 (7.0) | |
| 60+ | 68 (41.0) | 33 (19.9) | 37 (22.3) | 21 (12.7) | 7 (4.2) | |
| Total n, % (95% CI) | 576, 38.9 (36.4–41.4) | 370, 25.0 (22.9–27.3) | 339, 22.9 (20.8–25.1) | 144, 9.7 (8.3–11.3) | 52, 3.5 (2.7–4.6) | |
aSick leave days in the 6 weeks prior to testing.